Ceres Pharma, a pharmaceutical company, completed the acquisition of ABOPharma, a marketing and sales company active in food supplements and medical devices in Bulgaria. Financial terms were not disclosed. "I am extremely happy that we have come to an agreement with ABOPharma. This acquisition fits perfectly within our company strategy to further develop Ceres Pharma in Central and Eastern Europe. Ceres Pharma and ABOPharma share the same growth vision and commercial strategy. The ABOPharma brands are well known by Bulgarian doctors, pharmacists and consumers and very visible in the Bulgarian pharmacies and drugstores," Mario Debel, Ceres Pharma CEO.